WELL HEALTH TECHNOLOGIES (WELL-DB.CA) Fundamental Analysis & Valuation

TSX:WELL-DB • CA94947LAC69

Current stock price

100.19 CAD
+0.2 (+0.2%)
Last:

This WELL-DB.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. WELL-DB.CA Profitability Analysis

1.1 Basic Checks

  • WELL-DB had negative earnings in the past year.
  • In the past year WELL-DB has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: WELL-DB reported negative net income in multiple years.
  • WELL-DB had a positive operating cash flow in 4 of the past 5 years.
WELL-DB.CA Yearly Net Income VS EBIT VS OCF VS FCFWELL-DB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

  • WELL-DB has a Return On Assets of -2.14%. This is in the lower half of the industry: WELL-DB underperforms 61.54% of its industry peers.
  • WELL-DB's Return On Equity of -5.12% is on the low side compared to the rest of the industry. WELL-DB is outperformed by 61.54% of its industry peers.
Industry RankSector Rank
ROA -2.14%
ROE -5.12%
ROIC N/A
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
WELL-DB.CA Yearly ROA, ROE, ROICWELL-DB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

  • Looking at the Gross Margin, with a value of 39.97%, WELL-DB is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
  • WELL-DB's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for WELL-DB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
WELL-DB.CA Yearly Profit, Operating, Gross MarginsWELL-DB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. WELL-DB.CA Health Analysis

2.1 Basic Checks

  • WELL-DB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, WELL-DB has more shares outstanding
  • The number of shares outstanding for WELL-DB has been increased compared to 5 years ago.
  • WELL-DB has a better debt/assets ratio than last year.
WELL-DB.CA Yearly Shares OutstandingWELL-DB.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
WELL-DB.CA Yearly Total Debt VS Total AssetsWELL-DB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 13.60 indicates that WELL-DB is not in any danger for bankruptcy at the moment.
  • WELL-DB has a Altman-Z score of 13.60. This is amongst the best in the industry. WELL-DB outperforms 100.00% of its industry peers.
  • A Debt/Equity ratio of 0.67 indicates that WELL-DB is somewhat dependend on debt financing.
  • WELL-DB has a better Debt to Equity ratio (0.67) than 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Altman-Z 13.6
ROIC/WACCN/A
WACC7.88%
WELL-DB.CA Yearly LT Debt VS Equity VS FCFWELL-DB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 0.92 indicates that WELL-DB may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.92, WELL-DB is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
  • A Quick Ratio of 0.92 indicates that WELL-DB may have some problems paying its short term obligations.
  • WELL-DB has a Quick ratio of 0.92. This is in the better half of the industry: WELL-DB outperforms 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.92
WELL-DB.CA Yearly Current Assets VS Current LiabilitesWELL-DB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. WELL-DB.CA Growth Analysis

3.1 Past

  • WELL-DB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -200.00%.
  • The Revenue has grown by 26.20% in the past year. This is a very strong growth!
  • WELL-DB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 94.78% yearly.
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.18%
Revenue 1Y (TTM)26.2%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%44.83%

3.2 Future

  • WELL-DB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.72% yearly.
  • Based on estimates for the next years, WELL-DB will show a quite strong growth in Revenue. The Revenue will grow by 15.80% on average per year.
EPS Next Y179.65%
EPS Next 2Y67.99%
EPS Next 3Y40.74%
EPS Next 5Y19.72%
Revenue Next Year41.58%
Revenue Next 2Y25.63%
Revenue Next 3Y19.16%
Revenue Next 5Y15.8%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
WELL-DB.CA Yearly Revenue VS EstimatesWELL-DB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
WELL-DB.CA Yearly EPS VS EstimatesWELL-DB.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4

More info and screens

Find the best growth stocksShow best growing peers

2

4. WELL-DB.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • WELL-DB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 236.69, which means the current valuation is very expensive for WELL-DB.
  • WELL-DB's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 22.79. WELL-DB is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 236.69
WELL-DB.CA Price Earnings VS Forward Price EarningsWELL-DB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 -200 -400 -600 -800

4.2 Price Multiples

  • WELL-DB's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 286.23
WELL-DB.CA Per share dataWELL-DB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as WELL-DB's earnings are expected to grow with 40.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y67.99%
EPS Next 3Y40.74%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. WELL-DB.CA Dividend Analysis

5.1 Amount

  • No dividends for WELL-DB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

WELL-DB.CA Fundamentals: All Metrics, Ratios and Statistics

WELL HEALTH TECHNOLOGIES

TSX:WELL-DB (3/25/2026, 7:00:00 PM)

100.19

+0.2 (+0.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-19
Earnings (Next)05-12
Inst Owners3.73%
Inst Owner ChangeN/A
Ins Owners22.62%
Ins Owner ChangeN/A
Market Cap25.60B
Revenue(TTM)1.21B
Net Income(TTM)-43.25M
Analysts82.11
Price Target181.47 (81.13%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-37.08%
Min EPS beat(2)-41.18%
Max EPS beat(2)-32.99%
EPS beat(4)0
Avg EPS beat(4)-244.03%
Min EPS beat(4)-696.08%
Max EPS beat(4)-32.99%
EPS beat(8)2
Avg EPS beat(8)1902.08%
EPS beat(12)3
Avg EPS beat(12)1068.91%
EPS beat(16)3
Avg EPS beat(16)736.43%
Revenue beat(2)0
Avg Revenue beat(2)-2.27%
Min Revenue beat(2)-3.29%
Max Revenue beat(2)-1.25%
Revenue beat(4)1
Avg Revenue beat(4)-3.89%
Min Revenue beat(4)-12.61%
Max Revenue beat(4)1.59%
Revenue beat(8)3
Avg Revenue beat(8)-1.47%
Revenue beat(12)5
Avg Revenue beat(12)-0.69%
Revenue beat(16)9
Avg Revenue beat(16)0.17%
PT rev (1m)0%
PT rev (3m)-7.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)32.66%
EPS NY rev (3m)-0.5%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)0.19%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 236.69
P/S 21.18
P/FCF N/A
P/OCF N/A
P/B 30.32
P/tB N/A
EV/EBITDA 286.23
EPS(TTM)-0.12
EYN/A
EPS(NY)0.42
Fwd EY0.42%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS4.73
BVpS3.3
TBVpS-2.54
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.14%
ROE -5.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.97%
FCFM N/A
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
F-Score1
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Debt/EBITDA 6.23
Cap/Depr 27.43%
Cap/Sales 2.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.92
Quick Ratio 0.92
Altman-Z 13.6
F-Score1
WACC7.88%
ROIC/WACCN/A
Cap/Depr(3y)15.79%
Cap/Depr(5y)16.17%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.18%
EPS Next Y179.65%
EPS Next 2Y67.99%
EPS Next 3Y40.74%
EPS Next 5Y19.72%
Revenue 1Y (TTM)26.2%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%44.83%
Revenue Next Year41.58%
Revenue Next 2Y25.63%
Revenue Next 3Y19.16%
Revenue Next 5Y15.8%
EBIT growth 1Y-102.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year292.48%
EBIT Next 3Y65.66%
EBIT Next 5Y47.63%
FCF growth 1Y-170.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-132.25%
OCF growth 3Y-22.85%
OCF growth 5YN/A

WELL HEALTH TECHNOLOGIES / WELL-DB.CA Fundamental Analysis FAQ

What is the fundamental rating for WELL-DB stock?

ChartMill assigns a fundamental rating of 3 / 10 to WELL-DB.CA.


What is the valuation status of WELL HEALTH TECHNOLOGIES (WELL-DB.CA) stock?

ChartMill assigns a valuation rating of 2 / 10 to WELL HEALTH TECHNOLOGIES (WELL-DB.CA). This can be considered as Overvalued.


Can you provide the profitability details for WELL HEALTH TECHNOLOGIES?

WELL HEALTH TECHNOLOGIES (WELL-DB.CA) has a profitability rating of 2 / 10.


What is the financial health of WELL HEALTH TECHNOLOGIES (WELL-DB.CA) stock?

The financial health rating of WELL HEALTH TECHNOLOGIES (WELL-DB.CA) is 4 / 10.


What is the expected EPS growth for WELL HEALTH TECHNOLOGIES (WELL-DB.CA) stock?

The Earnings per Share (EPS) of WELL HEALTH TECHNOLOGIES (WELL-DB.CA) is expected to grow by 179.65% in the next year.